To evaluate the potential clinical significance of the BCKDK‐mediated regulatory pathway in patient samples, we first assessed the levels of BCKDK, p‐RNF8S157, and RAD51 in 14 paired breast cancer lesions and adjacent noncancerous tissue samples. This evidence concerns the gene RAD51 and breast carcinoma.